Showing results (271-280 of 399) with videos related to

Sort By:
Pageof 40
Journal for Immunotherapy of Cancer|January 28, 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myelomaBinod Dhakal, Parameswaran Hari, Saurabh Chhabra, et al.
Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host diseaseDaniel H Fowler, Jason Foley, Jeannie Whit-Shan Hou, et al.
Experimental Hematology|May 22, 2013
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemiaBrian C Shaffer, Marko Modric, Maryalice Stetler-Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantationRachel B Salit, Daniel H Fowler, Robert M Dean, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasKristin Baird, Terry J Fry, Seth M Steinberg, et al.
Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejectionJacopo Mariotti, Jason Foley, Unsu Jung, et al.
Pageof 40